Category:NA-importance pharmacology articles
Appearance
![]() | This is a maintenance category, used for maintenance of the Wikipedia project. It is not part of the encyclopedia and contains non-article pages, or groups articles by status rather than subject. Do not include this category in content categories. |
![]() | Administrators: Please do not delete this category as empty! This category may be empty occasionally or even most of the time. |
Top | High | Mid | Low | NA | ??? |
119 | 876 | 3,106 | 6,433 | 2,384 | 3,317 |
Pages in category "NA-importance pharmacology articles"
The following 200 pages are in this category, out of approximately 2,384 total. This list may not reflect recent changes.
(previous page) (next page)D
- Talk:Daliresp
- Draft talk:Dan Berlau
- Talk:Danlox
- Talk:Darifenacin hydrobromide
- Talk:Deep Heat (heat rub)
- Category talk:Defunct pharmaceutical companies
- Category talk:Defunct pharmaceutical companies of Denmark
- Category talk:Defunct pharmaceutical companies of the United States
- Category talk:Defunct pharmacies
- Category talk:Deliriants
- Category talk:Delta-opioid receptor agonists
- Category talk:Delta-opioid receptor antagonists
- Talk:Demeprazol
- Talk:Demerol
- Template talk:Demyelinating diseases of CNS
- Template talk:Dependence treatment
- Talk:Depon
- Template talk:Depressants
- Category talk:Dermatologic drug stubs
- Category talk:Dermatologic drugs
- Talk:Desec
- Talk:Desoxycorticosterone
- Category talk:Detoxification
- Template talk:Detoxifying agents for antineoplastic treatment
- Talk:Development of analogs of thalidomide
- Talk:Dextrose
- Template talk:Diagnostic agents
- Template talk:Diagnostic radiopharmaceuticals
- Talk:Diclectin
- Template talk:Did you know nominations/Coalition for Epidemic Preparedness Innovations
- Template talk:Digestives
- Talk:Digital therapeutic
- Talk:Dihydroequilenin
- Talk:Dihydroequilin
- Category talk:Dihydrofolate reductase inhibitors
- Category talk:Dihydropteroate synthetase inhibitors
- Category talk:Dipeptidyl peptidase-4 inhibitors
- Talk:Diphemethoxidine
- Talk:Diphenhydramine citrate
- Category talk:Diphenylbutylpiperidines
- Talk:Dipine
- Category talk:Direct thrombin inhibitors
- Talk:Direct-acting antivirals
- Category talk:Disambig-Class pharmacology articles
- Talk:Discovery and development of dual serotonin and norepinephrine reuptake inhibitors
- Talk:Discovery and development of renin inhibitors
- Talk:Discovery and development of selective progesterone receptor modulators
- Talk:Discovery and development of tubulin inhibitors
- Category talk:Dissociative drugs
- Talk:Distomer
- Category talk:Dithiocarbamates
- Category talk:Diuretics
- Template talk:Diuretics
- Talk:Diuril
- Talk:Dizprazol
- Template talk:DNA antivirals
- Category talk:DNA replication inhibitors
- Talk:Doburil
- Category talk:Documentary films about drug addiction
- Category talk:Documentary films about drugs
- Category talk:Documentary films about LSD
- Category talk:Documentary films about the illegal drug trade
- Category talk:Dopamine agonists
- Category talk:Dopamine antagonists
- Template talk:Dopamine receptor modulators
- Category talk:Dopamine reuptake inhibitors
- Category talk:Doping at the Tour de France
- Template talk:Doping at the Tour de France
- Category talk:Doping cases in auto racing
- Category talk:Doping cases in canoeing
- Category talk:Doping cases in kickboxing
- Category talk:Doping cases in sport
- Category talk:Doping in sport
- Category talk:Dosage forms
- Talk:Dose concentration
- Category talk:Draft-Class pharmacology articles
- Category talk:Drug advertising
- Category talk:Drug brand names
- Category talk:Drug control case law
- Category talk:Drug delivery devices
- Category talk:Drug discovery
- Category talk:Drug eruptions
- Category talk:Drug list templates
- Category talk:Drug navigational boxes
- Category talk:Drug policy
- Template talk:Drug policy nav
- Category talk:Drug policy of Austria
- Category talk:Drug policy of Taiwan
- Talk:Drug prices
- Category talk:Drug sidebar templates
- Category talk:Drug templates
- Category talk:Drug templates by ATC
- Category talk:Drug templates by receptor, channel, or pump
- Category talk:Drug templates by structure
- Template talk:Drug use
- Talk:Drug user
- Category talk:Drug-induced diseases
- Category talk:Drug-related deaths in Colorado
- Category talk:Drug-related deaths in England
- Category talk:Drug-related deaths in Macau
- Category talk:Drug-related deaths in Maine
- Category talk:Drug-related deaths in New York City
- Category talk:Drug-related deaths in Papua New Guinea
- Category talk:Drug-related lists
- Category talk:Drug-related suicides in Illinois
- Category talk:Drug-related suicides in Maine
- Category talk:Drug-related suicides in Massachusetts
- Category talk:Drug-related suicides in Nevada
- Category talk:Drug-related suicides in South Carolina
- Category talk:Drug-related suicides in the United States by state
- Category talk:Drugs
- Category talk:Drugs acting on the cardiovascular system
- Category talk:Drugs acting on the gastrointestinal system and metabolism
- Category talk:Drugs acting on the genito-urinary system
- Category talk:Drugs acting on the musculoskeletal system
- Category talk:Drugs acting on the nervous system
- Category talk:Drugs acting on the respiratory system
- Category talk:Drugs by country
- Category talk:Drugs by dependent territory
- Category talk:Drugs by location
- Category talk:Drugs by mechanism of action
- Category talk:Drugs by psychological effects
- Category talk:Drugs by target organ system
- Category talk:Drugs developed by Bayer
- Category talk:Drugs developed by GSK plc
- Category talk:Drugs developed by Johnson & Johnson
- Category talk:Drugs developed by Pfizer
- Category talk:Drugs developed by Schering-Plough
- Category talk:Drugs developed by Wyeth
- Template talk:Drugs for functional gastrointestinal disorders
- Template talk:Drugs for obstructive airway diseases
- Template talk:Drugs for peptic ulcer and GORD
- Template talk:Drugs for treatment of bone diseases
- Template talk:Drugs for treatment of hyperkalemia and hyperphosphatemia
- Category talk:Drugs in Algeria
- Category talk:Drugs in Australia
- Category talk:Drugs in Benin
- Category talk:Drugs in Burundi
- Category talk:Drugs in Cyprus
- Category talk:Drugs in Estonia
- Category talk:Drugs in sport
- Category talk:Drugs in sport by country
- Category talk:Drugs in Taiwan
- Category talk:Drugs in the State of Palestine
- Category talk:Drugs in the Turks and Caicos Islands
- Category talk:Drugs in Turkey
- Category talk:Drugs in Yemen
- Category talk:Drugs not assigned an ATC code
- Template talk:Drugs used in benign prostatic hypertrophy
- Talk:Dryvax
- Talk:Dudencer
- Talk:Dulcolax
- Talk:Duoneb
- Talk:Dusodril
- Talk:Dyazide
- Talk:Dynepo
E
- Talk:E-cigarette
- Talk:E-Cigarette
- Talk:Echinopsis scopulicola
- Talk:Ecstasy (drug)
- Talk:Eczemol
- Talk:Edarbi
- Talk:Edecrin
- Talk:Efavirenz, emtricitabine, tenofovir disoproxil succinate
- Category talk:Effects of psychoactive drugs
- Talk:Eglonyl
- Talk:Elaterium
- Category talk:Electronic cigarettes
- Template talk:Electronic cigarettes
- Category talk:Element toxicology
- Talk:Elgam
- Category talk:Eltoprazines
- Category talk:Embryotoxins
- Talk:Emeproton
- Category talk:Emetics
- Template talk:Emollients and protectives
- Talk:Emsam
- Talk:Emselex
- Talk:Enablex
- Category talk:Endocannabinoid reuptake inhibitors
- Category talk:Endothelin receptor agonists
- Category talk:Endothelin receptor antagonists
- Template talk:Engineered antibodies
- Category talk:Enkephalinase inhibitors
- Talk:Ensifentrine
- Category talk:Entheogens
- Talk:Environmental fate and occurrence of carbamazepine
- Talk:Environmental hormones
- Talk:Environmental impact of pharmaceutical packaging
- Talk:Epinephrine
- Talk:Epirazole
- Talk:Epoprostenol
- Talk:Equianalgesic/Archive 1
- Category talk:Equine medications
- Talk:Equipotent molar ratio
- Talk:Erbolin
- Category talk:Erectile dysfunction drugs
- Talk:Ergogenic aid
- Talk:Ergogenic aids
- Talk:Ergogenic drug